Mark Burkard
Associate Dean for Cancer, Carver College of Medicine · Roy J. and Lucille A. Carver College of Medicine
Credentials: · · · · · · ·
History
PresentCarver College of Medicine · Roy J. and Lucille A. Carver College of Medicine
- Present
Cancer Research Department · University of Iowa Health Care Medical Center
2024–Present
- 2006–2008
Medical Oncology
2002–2006
1994–2002- 1990–1994
Research
Biochemistry · 1998 · 936 citations
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
New England Journal of Medicine · 2020 · 631 citations
Selective RET kinase inhibition for patients with RET-altered cancers
Case report · Annals of Oncology · 2018 · 351 citations
18 papers
13 papers
11 papers
11 papers · 1 as a fellow
- BP
7 papers
6 papers · 3 as a fellow
5 papers
5 papers
Grants
- 2024–2029
Mechanisms of Paclitaxel Sensitivity and Resistance
National Cancer Institute · R01
PI · $1.6M · University of Wisconsin-Madison
- 2000–2027
- 2021–2026
Integrated Training For Physician-Scientists
National Institute of General Medical Sciences · T32
Contact PI · $3.2M · University of Wisconsin-Madison
- 2021–2025
Mechanisms of Plk1 at the Mitotic Centromere
National Institute of General Medical Sciences · R01
Contact PI · $916.8K · University of Wisconsin-Madison
Clinical trials
- 2018–2024
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
Principal investigator · Terminated
University of Wisconsin, Madison
- 2017–2018
Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
Principal investigator · Withdrawn · Phase 2
University of Wisconsin, Madison
- 2010–2013
Principal investigator · Completed · Early phase 1
University of Wisconsin, Madison
- 2025–2033
Site PI · Recruiting · Phase 3
Eli Lilly and Company
Honors
American Society for Clinical Investigation (ASCI)
2021American Society for Clinical Investigation